WCN26-2437 β-CARYOPHYLLENE AMELIORATES EXPERIMENTAL DIABETIC NEPHROPATHY VIA CB2-DEPENDENT, α-KLOTHO–MEDIATED ACTIVATION OF THE RENAL Nrf2/Keap1/HO-1 AXIS

Read full text Summarise with VIRAT
Authors: Bushra Zia, Mohamed Fizur Nagoor Meeran, Sheikh Azim, Shreesh Kumar Ojha
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Despite significant advancement in management of diabetes, one of the diabetic complication, diabetic nephropathy (DN) is a therapeutic enigma characterized by progressive kidney damage. β-caryophyllene (BCP), a naturally available dietary cannabinoid recognized as a cannabinoid receptor type 2 (CB2) agonist, has shown to confer protection in in different organs in diabetic conditions. However, the role of BCP in DN is not yet known, therefore the present study evaluated its role in experimental models of DN and underlying mechanisms.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Cannabis and Cannabinoid Research Genomics phytochemicals and oxidative stress

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104592–104592
Publication date
25 March 2026
Language
EN